Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe site revision was updated to v3.3.2 and v3.2.0 was removed; this is a minor metadata update that does not affect the study details or trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedStudy status updated to Completed with updated completion date and last update timestamp; the page reflects the current state of the trial and its recent activity.SummaryDifference1.0%

- Check42 days agoChange Detected- The page shows minor editorial edits and a new last-updated timestamp; core study content, eligibility criteria, locations, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedThe page updates primarily refresh date-related content (new dates added, old dates removed) and IPD planning labels, with no major changes to core content or pricing.SummaryDifference2%

- Check71 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference4%

- Check78 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.